omimdefinitions
-
| * 611259 CDK5 REGULATORY SUBUNIT-ASSOCIATED PROTEIN 1-LIKE 1| CDKAL1
-
| {?Hearing loss, cisplatin-induced, susceptibility to} (2)
-
| * 607145 DYSTROBREVIN-BINDING PROTEIN 1| DTNBP1
-
| Hermansky-Pudlak syndrome 7, 614076 (3)
-
| Epilepsy, progressive myoclonic 2B (Lafora), 254780 (3)
-
| Treacher Collins syndrome 3, 248390 (3)
-
| Otosclerosis 3 (2)
-
| 6-mercaptopurine sensitivity, 610460 (3)
-
| Deafness, autosomal recessive 66 (2)
-
| {Dyslexia, susceptibility to, 2}, 600202 (3)
-
| [C3HEX, ability to smell], 615082 (3)
-
| {Stature QTL 18} (2)
-
| Diabetes mellitus, transient neonatal, 1, 601410 (3)
-
| Succinic semialdehyde dehydrogenase deficiency, 271980 (3)
-
| {Alkaline phosphatase, plasma level of, QTL3} (2)
-
| {Neuroblastoma, susceptibility to, 4} (2)
-
| Fanconi anemia, complementation group E, 600901 (3)
-
| ?Antiphospholipid syndrome, familial (2)
-
| {Follicular lymphoma, susceptibility to, 1} (2)
-
| {Lung cancer susceptibility 4} (2)
-
| Ichthyosis, congenital, autosomal recessive 10, 615024 (3)
-
| Spermatogenic failure 3, 606766 (3)
-
| {Stature QTL 19} (2)
-
| ?Mitochondrial complex III deficiency, nuclear type 7, 615824 (3)
-
| {Sarcoidosis, susceptibility to, 2}, 612387 (3)
-
| C2 deficiency, 217000 (3)
-
| {Macular degeneration, age-related, 14, reduced risk of}, 615489 (3)
-
| C4a deficiency, 614380 (3)
-
| [Blood group, Rodgers], 614374 (3)
-
| * 120810 COMPLEMENT COMPONENT 4A| C4A
-
| C4B deficiency, 614379 (3)
-
| Hypotrichosis 2, 146520 (3)
-
| Peeling skin syndrome, 270300 (3)
-
| * 138470 COMPLEMENT FACTOR B| CFB
-
| {Hemolytic uremic syndrome, atypical, susceptibility to, 4}, 612924 (3)
-
| ?Complement factor B deficiency, 615561 (3)
-
| Stickler syndrome, type III, 184840 (3)
-
| Otospondylomegaepiphyseal dysplasia, 215150 (3)
-
| Weissenbacher-Zweymuller syndrome, 277610 (3)
-
| Deafness, autosomal dominant 13, 601868 (3)
-
| Deafness, autosomal recessive 53, 609706 (3)
-
| Fibrochondrogenesis 2, 614524 (3)
-
| {Pulmonary hypertension, chronic thromboembolic, without deep vein thrombosis, susceptibility to} (2)
-
| Adrenal hyperplasia, congenital, due to 21-hydroxylase deficiency, 201910 (3)
-
| * 613815 CYTOCHROME P450, FAMILY 21, SUBFAMILY A, POLYPEPTIDE 2| CYP21A2
-
| Deafness, autosomal dominant 31 (2)
-
| Hemochromatosis, 235200 (3)
-
| {Microvascular complications of diabetes 7}, 612635 (3)
-
| * 613609 HFE GENE| HFE
-
| {Porphyria cutanea tarda, susceptibility to}, 176100 (3)
-
| {Alzheimer disease, susceptibility to}, 104300 (3)
-
| [Transferrin serum level QTL2], 614193 (3)
-
| {Hypersensitivity syndrome, carbamazepine-induced, susceptibility to}, 608579 (3)
-
| {Spondyloarthropathy, susceptibility to, 1}, 106300 (3)
-
| {Abacavir hypersensitivity, susceptibility to} (3)
-
| {Synovitis, chronic, susceptibility to} (3)
-
| {Drug-induced liver injury due to flucloxacillin} (3)
-
| {Toxic epidermal necrolysis, susceptibility to}, 608579 (3)
-
| {Stevens-Johnson syndrome, susceptibility to}, 608579 (3)
-
| {Psoriasis susceptibility 1}, 177900 (3)
-
| * 142840 MAJOR HISTOCOMPATIBILITY COMPLEX, CLASS I, C| HLA-C
-
| * 142858 MAJOR HISTOCOMPATIBILITY COMPLEX, CLASS II, DP BETA-1| HLA-DPB1
-
| {Celiac disease, susceptibility to}, 212750 (3)
-
| {Creutzfeldt-Jakob disease, variant, resistance to}, 123400 (3)
-
| * 604305 MAJOR HISTOCOMPATIBILITY COMPLEX, CLASS II, DQ BETA-1| HLA-DQB1
-
| {Celiac disease, susceptibility to}, 212750 (3)
-
| * 142857 MAJOR HISTOCOMPATIBILITY COMPLEX, CLASS II, DR BETA-1| HLA-DRB1
-
| {Sarcoidosis, susceptibility to, 1}, 181000 (3)
-
| {Multiple sclerosis, susceptibility to, 1}, 126200 (3)
-
| {Rheumatoid arthritis, susceptibility to}, 180300 (3)
-
| * 142871 HLA-G HISTOCOMPATIBILITY ANTIGEN, CLASS I| HLA-G
-
| {Inflammatory bowel disease 3} (2)
-
| {Diabetes mellitus, insulin-dependent-1} (2)
-
| Immunoglobulin A deficiency (2)
-
| Deafness, autosomal recessive 67, 610265 (3)
-
| * 153440 LYMPHOTOXIN-ALPHA| LTA
-
| {Psoriatic arthritis, susceptibility to}, 607507 (3)
-
| {Leprosy, susceptibility to, 4}, 610988 (3)
-
| Molybdenum cofactor deficiency A, 252150 (3)
-
| Narcolepsy 7, 614250 (3)
-
| Myasthenia gravis with thymus hyperplasia (2)
-
| {Malaria, mild, susceptibility to}, 609148 (3)
-
| Sialidosis, type I, 256550 (3)
-
| * 608272 NEURAMINIDASE 1| NEU1
-
| * 601022 NUCLEAR FACTOR OF KAPPA LIGHT CHAIN GENE ENHANCER IN B CELLS INHIBITOR-LIKE
-
| {?Membranous nephropathy, susceptibility to} (2)
-
| {Nasopharyngeal carcinoma, susceptibility to, 2} (2)
-
| {Biliary cirrhosis, primary, 2} (2)
-
| ?Diabetes mellitus, insulin-dependent, neonatal (2)
-
| Panbronchiolitis, diffuse (2)
-
| {Podoconiosis, susceptibility to} (2)
-
| ?Paget disease of bone (2)
-
| Autoinflammation, lipodystrophy, and dermatosis syndrome, 256040 (3)
-
| ?Ragweed sensitivity (2)
-
| [Uric acid concentration, serum, QTL4], 612671 (3)
-
| * 611034 SOLUTE CARRIER FAMILY 17 (SODIUM PHOSPHATE COTRANSPORTER), MEMBER
-
| Mental retardation, autosomal dominant 5, 612621 (3)
-
| Bare lymphocyte syndrome, type I, 604571 (3)
-
| * 170261 TRANSPORTER, ATP-BINDING CASSETTE, MAJOR HISTOCOMPATIBILITY COMPLEX,
-
| Wegener-like granulomatosis (3)
Document Actions